By Thomas Lee
MINNEAPOLIS, Minnesota — Let the fundraising begin!
Miromatrix Inc., a start-up trying to commercialize the regenerative tissue research of Doris Taylor, has reached an agreement to license the technology from the University of Minnesota, a move that allows the company to formally raise seed money.
